drugset / Trial / NCT04398225
A Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Centanafadine in Pediatric Subjects With Attention-deficit/Hyperactivity Disorder
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This trial will evaluate the pharmacokinetics, safety, and tolerability of centanafadine in pediatric subjects with ADHD.
Timeline
- Start
- 2020-06-11
- Primary completion
- 2021-04-01
- Completion
- 2021-04-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Centanafadine | Small molecule | 100 mg | Oral |
| Subject | Centanafadine | Small molecule | 200 mg | Oral |
| Subject | Centanafadine | Small molecule | 400 mg | Oral |